Company & Sponsor Intelligence
Centre Hospitalier Rouffach
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting1
Completed0
Countries1
Therapeutic footprint
depression
Indexed studies
NCT05813756Validation Study of the Coping, Motivation and Post-diagnosis Psychoeducation Program for Adults With Autism
autism · FranceNA
autism · FranceNA
NCT05964192Added Value of a Neuroendocrine Test Battery in the Response to Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment
depression · FranceNA
depression · FranceNA
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →